| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Pyruvaldehyde |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01448
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Health Hazard |
| DME Modulation |
Pyruvaldehyde induces the drug-metabolizing activity of DME AKR7A2 |
[1] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| 14-deoxy-11,12-didehydroandrographolide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01095
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
14-deoxy-11,12-didehydroandrographolide inhibits the expression of DME AKR7A2 |
[2] |
| 7-hydroxycoumarin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01174
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
7-hydroxycoumarin induces the drug-metabolizing activity of DME AKR7A2 |
[3], [4] |
| Traditional Medicine |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Jinfukang |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00760
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Traditional Medicine |
| DME Modulation |
Jinfukang up-regulates the expression of DME AKR7A2 |
[5] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen up-regulates the expression of DME AKR7A2 |
[6] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin up-regulates the expression of DME AKR7A2 |
[7] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME AKR7A2 |
[8] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME AKR7A2 |
[9], [10] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME AKR7A2 |
[11] |
| Hydrogen peroxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00388
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Hydrogen peroxide induces the drug-metabolizing activity of DME AKR7A2 |
[3] |
| Piroxicam |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00204
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Piroxicam inhibits the drug-metabolizing activity of DME AKR7A2 |
[12] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| ICG-001 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 up-regulates the expression of DME AKR7A2 |
[13] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 4-hydroxy-2-nonenal |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00869
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Investigative Agent |
| DME Modulation |
4-hydroxy-2-nonenal induces the drug-metabolizing activity of DME AKR7A2 |
[3], [4] |
|
|
|
|
|
|